142 related articles for article (PubMed ID: 20513182)
21. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.
Zak A; Siwinska N; Elzinga S; Barker VD; Stefaniak T; Schanbacher BJ; Place NJ; Niedzwiedz A; Adams AA
Domest Anim Endocrinol; 2020 Jul; 72():106476. PubMed ID: 32380311
[TBL] [Abstract][Full Text] [Related]
22. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
Liu Z; Miers WR; Wei L; Barrett EJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
[TBL] [Abstract][Full Text] [Related]
23. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women.
Kim JS; Cross JM; Bamman MM
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1110-9. PubMed ID: 15644458
[TBL] [Abstract][Full Text] [Related]
24. Exercise-induced increases in inflammatory cytokines in muscle and blood of horses.
Liburt NR; Adams AA; Betancourt A; Horohov DW; McKeever KH
Equine Vet J Suppl; 2010 Nov; (38):280-8. PubMed ID: 21059019
[TBL] [Abstract][Full Text] [Related]
25. Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model.
Lenk K; Schur R; Linke A; Erbs S; Matsumoto Y; Adams V; Schuler G
Eur J Heart Fail; 2009 Apr; 11(4):342-8. PubMed ID: 19218333
[TBL] [Abstract][Full Text] [Related]
26. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors.
Mbebi C; Hantaï D; Jandrot-Perrus M; Doyennette MA; Verdière-Sahuqué M
J Cell Physiol; 1999 Jun; 179(3):305-14. PubMed ID: 10228949
[TBL] [Abstract][Full Text] [Related]
27. Computed tomographic findings in the pituitary gland and brain of horses with pituitary pars intermedia dysfunction.
Pease AP; Schott HC; Howey EB; Patterson JS
J Vet Intern Med; 2011; 25(5):1144-51. PubMed ID: 21985144
[TBL] [Abstract][Full Text] [Related]
28. Increased interleukin-1beta mRNA expression in skin biopsies of horses with Culicoides hypersensitivity following challenge with Culicoides nubeculosus extract.
Kolm G; Knapp E; Wagner R; Klein D
Vet Immunol Immunopathol; 2006 Sep; 113(1-2):90-8. PubMed ID: 16797083
[TBL] [Abstract][Full Text] [Related]
29. Branched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states?
Busquets S; Alvarez B; López-Soriano FJ; Argilés JM
J Cell Physiol; 2002 Jun; 191(3):283-9. PubMed ID: 12012323
[TBL] [Abstract][Full Text] [Related]
30. Agreement in histologic assessments of the pituitary pars intermedia in aged horses.
McFarlane D; Miller LM; Craig LE; Dybdal NO; Habecker PL; Miller MA; Patterson JS; Cribb AE
Am J Vet Res; 2005 Dec; 66(12):2055-9. PubMed ID: 16379646
[TBL] [Abstract][Full Text] [Related]
31. Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease.
McFarlane D
Ageing Res Rev; 2007 May; 6(1):54-63. PubMed ID: 17374512
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of MUC5AC expression and upregulation in airway epithelial cells of horses.
Oslund KL; Adamson G; Wu R
Am J Vet Res; 2010 Jun; 71(6):690-6. PubMed ID: 20513186
[TBL] [Abstract][Full Text] [Related]
33. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy.
Fortin JS; Hetak AA; Duggan KE; Burglass CM; Penticoff HB; Schott HC
Sci Rep; 2021 Aug; 11(1):16036. PubMed ID: 34362943
[TBL] [Abstract][Full Text] [Related]
34. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
35. Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy.
Banse HE; Whitehead AE; McFarlane D; Chelikani PK
Domest Anim Endocrinol; 2021 Jul; 76():106620. PubMed ID: 33740552
[TBL] [Abstract][Full Text] [Related]
36. Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle.
Murphy RM; Verburg E; Lamb GD
J Physiol; 2006 Oct; 576(Pt 2):595-612. PubMed ID: 16857710
[TBL] [Abstract][Full Text] [Related]
37. Expression of inflammation-associated genes in circulating leukocytes collected from horses with gastrointestinal tract disease.
Lopes MA; Salter CE; Vandenplas ML; Berghaus R; Hurley DJ; Moore JN
Am J Vet Res; 2010 Aug; 71(8):915-24. PubMed ID: 20673091
[TBL] [Abstract][Full Text] [Related]
38. Effect of kinin B2 receptor ablation on skeletal muscle development and myostatin gene expression.
de Picoli Souza K; Batista EC; Silva ED; Reis FC; Silva SM; Araujo RC; Luz J; Santos EL; Pesquero JB
Neuropeptides; 2010 Apr; 44(2):209-14. PubMed ID: 20045188
[TBL] [Abstract][Full Text] [Related]
39. Increased mucus accumulation in horses chronically affected with recurrent airway obstruction is not associated with up-regulation of CLCA1, EGFR, MUC5AC, Bcl-2, IL-13 and INF-gamma expression.
Ryhner T; Müller N; Balmer V; Gerber V
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):8-17. PubMed ID: 18597857
[TBL] [Abstract][Full Text] [Related]
40. Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells.
Chang LY; Wan HC; Lai YL; Kuo YF; Liu TY; Chen YT; Hung SL
J Periodontal Res; 2009 Apr; 44(2):175-83. PubMed ID: 18973534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]